IP
TEVA icon

Isthmus Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Isthmus Partners’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-14,627
Closed -$937K – 201
2019
Q1 		$937K Buy
+14,627
New +$258K 0.23% 90
2018
Q4 		– Sell
-312
Closed -$7K – 264
2018
Q3 		$7K Hold
312
– – ﹤0.01% 255
2018
Q2 		$8K Hold
312
– – ﹤0.01% 239
2018
Q1 		$5K Hold
312
– – ﹤0.01% 250
2017
Q4 		$6K Hold
312
– – ﹤0.01% 261
2017
Q3 		$5K Hold
312
– – ﹤0.01% 283
2017
Q2 		$10K Hold
312
– – ﹤0.01% 253
2017
Q1 		$10K Hold
312
– – ﹤0.01% 259
2016
Q4 		$11K Hold
312
– – ﹤0.01% 256
2016
Q3 		$14K Buy
+312
New +$16.3K ﹤0.01% 231

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return